share_log
Benzinga ·  Jul 23 08:00
EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga 'Patient Dosing in the Second Cohort Has Commenced Following the Successful Completion of the First Cohort'
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment